TRV GP III’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

TRV GP III’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,139,685	Closed	-$12.1M	–	2
2023 Q2	$12.1M	Hold	3,139,685	–	–	66.29%	1
2023 Q1	$9.48M	Hold	3,139,685	–	–	11.43%	3
2022 Q4	$6.44M	Hold	3,139,685	–	–	5.04%	5
2022 Q3	$10.9M	Hold	3,139,685	–	–	4.74%	5
2022 Q2	$13.2M	Hold	3,139,685	–	–	5.41%	6
2022 Q1	$9.54M	Hold	3,139,685	–	–	2.59%	6
2021 Q4	$14.6M	Hold	3,139,685	–	–	3.65%	6
2021 Q3	$24.2M	Hold	3,139,685	–	–	4.6%	5
2021 Q2	$27M	Hold	3,139,685	–	–	4.71%	5
2021 Q1	$35.7M	Buy	+3,139,685	New	+$49.3M	4.51%	5

Other funds holding DBTX

ACA

Atlas Capital Advisors Jackson, Wyoming $875M AUM

TRV GP III's DBTX Position: Q3 2023 in Review

TRV GP III sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 3,139,685 shares — an estimated $12.1M sold.

TRV GP III first reported a position in DBTX in Q1 2021 and held it in 10 quarters. The position peaked at $35.7M in Q1 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

TRV GP III reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
TRV GP III sold 3,139,685 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $12.1M.
TRV GP III first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
TRV GP III's Decibel Therapeutics, Inc. Common Stock position peaked at $35.7M in Q1 2021.
1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on TRV GP III's 13F filing for Q3 2023, filed 13 Nov 2023.